drugset / Trial / NCT00728728
Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will investigate adjunctive pregnenolone for patients with schizophrenia and schizoaffective disorder.
Timeline
- Start
- 2009-12
- Primary completion
- 2015-03
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pregnenolone | Other / unclassified | 250 mg | — |